# Yi Liu

> Yi Liu is a Series A investor at TF Capital backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [TF Capital](https://shizune.co/investors/profile/tf-capital)
- Total investments: 1
- Last investment: May 2022
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/allanyoyo/?original_referer=https%3A%2F%2Fwww%2Egoogle%2Ecom%2F&originalSubdomain=cn

Yi Liu is a Series A investor at TF Capital focused on Health Care and Biotechnology. Yi (Allan) Liu is a director at TF Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AskGene Pharma | AskGene Pharma is a biotechnology firm. It is developing novel cytokine prodrugs to address critical unmet medical needs in oncology and autoimmune disease. It is unlocking the full therapeutic potential of cytokine molecules with their innovative smart kine prodrug platform. It overcomes a number of significant challenges, providing a clearpathway to a range of next-generation cytokine therapies. They provide safer and better medicines for saving patients’ lives. They are equipped with the most advanced R&D facilities. | $20M | Series A | May 08, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 1 deal together

## About TF Capital

VC Fund · Pudong, China

TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.

4 contacts available at TF Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Dr. Zhang Yibo | Partner | https://shizune.co/investors/profile/dr-zhang-yibo |
| H.J. Jiang | Founder & CEO | https://shizune.co/investors/profile/kevin-chiang-fda9 |
| Wei Cheng | Managing Director | https://shizune.co/investors/profile/wei-cheng-2639 |
| Yi Liu | Director | https://shizune.co/investors/profile/yi-liu-0a01 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Yi Liu invest in?

Yi Liu invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Yi Liu last invest?

The most recent investment recorded for Yi Liu closed in May 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co